Investor FAQs

Investor FAQs

Show all

300 George Street, Suite 301
New Haven, CT 06511

300 Tri State International, Suite 272
Lincolnshire, IL 60069

Building Two Quadrangle
6320 Quadrangle Drive, Suite 360
Chapel Hill, NC 27517

44 Whippany Road, Suite 280
Morristown, NJ 07960
Melinta’s common stock trades on Nasdaq under the ticker “MLNT”
58549G 100
Computershare Limited
250 Royall Street
Canton, MA 02021
Melinta’s fiscal year ends on December 31
Melinta’s SEC filings, including quarterly and annual reports, can be found on the Investor Relations section of this website or directly from the SEC at

Melinta Therapeutics, Inc. ©2019 ALL RIGHTS RESERVED | Terms of Use